The administration of IVFs is nearly universal in critically ill patients. In recent years, several studies have suggested improved outcomes with the use of balanced crystalloids solutions in contrast to 0.9% NS. In this podcast, we discuss the recently published BaSICS Trial that evaluated Plasma-Lyte 148 with 0.9% NS in critically ill patients. Does this study provide practice-changing evidence to make that switch?
You can get CME credit for this episode hereClick here for CME Account Creation Instructions
A plethora of literature was published during the course of 2019. In this podcast, we review several key articles published in the 2019 critical...
Patients with acute liver failure can be incredibly sick and have an exceedingly high mortality. Early identification and prompt, evidence-based management of the patient...
Acute aortic syndromes such as aortic dissection are incredibly stressful and challenging to manage. In this episode, we tackle the difficult management pearls and...